Some pharmacokinetic and pharmacodynamic interactions between digoxin and gentamicin

Area of Science:

• Pharmacology
• Toxicology
• Drug Interactions

Background:

• Digoxin and gentamicin are commonly prescribed medications.
• Potential for pharmacokinetic and pharmacodynamic interactions exists between these drugs.
• Understanding these interactions is crucial for safe and effective patient care.

Purpose of the Study:

• To investigate the pharmacokinetic and pharmacodynamic interactions between digoxin and gentamicin.
• To assess the impact of gentamicin pretreatment on digoxin's pharmacokinetic parameters.
• To evaluate the effect of digoxin on gentamicin's neuromuscular blocking activity.

Main Methods:

• Experiments were conducted on rabbits, guinea-pigs, and cats.
• Pharmacokinetic parameters of digoxin (t1/2 alpha, t1/2 beta, AUC, AL) were analyzed.
• Digoxin toxicity was assessed using lethal dose studies in guinea-pigs.
• The effect of digoxin on gentamicin's neuromuscular blockade was studied using an isolated nerve-muscle preparation.

Main Results:

• Gentamicin pretreatment increased digoxin serum levels and altered its pharmacokinetic parameters in rabbits, dose-dependently.
• The most significant changes in digoxin kinetics occurred with simultaneous 5-day administration of digoxin and non-toxic gentamicin doses.
• Digoxin toxicity in guinea-pigs increased only at a very high gentamicin dose; non-toxic gentamicin doses showed no change or decreased toxicity.
• Digoxin attenuated the nerve-muscle blocking effect of gentamicin in cats.

Conclusions:

• Gentamicin can significantly alter digoxin pharmacokinetics, necessitating careful monitoring.
• The interaction's effect on digoxin toxicity is complex and may be dose-dependent.
• Digoxin may modulate the neuromuscular effects of gentamicin.